Received Jun 26, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | EN6204 | SYR / LA |
Chronic fatigue, regular exhaustion, brain fog, inability to focus/concentrate, fibromyalgia, tachycardia upon standing, exertion, shortness of breath, headaches, sleeplessness, paresthesia, neuropathy, permanent nerve damage to sex organs/complete sexual dysfunction, heart palpitations, inability to exercise, rapid weight gain (70 lb), IBS, GERD, chronic systemic inflammation, non-healing ulcerated, widespread, hyperkeratinous skin wounds (nose, face, neck, arms). Treatment is ongoing and involves numerous specialty cares. Outcome has been complete physical disability, home-boundness, and deep emotional trauma
T1D
T1D
Humalog, atorvastatin, campral,
Far too many to list, ongoing. Tests have been requested by the following medical care function: primary care, psychiatry, cardiology, gastroenerology, rheumatology, immunology, endocrinology, dermatology, urology